PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP)

Movement Disorders

Volumn 14, Issue 1, 1999, Pages 132-137

  Brashear, Allison ^a   Mulholland, G Keith ^a   Zheng, Qi Huang ^a   Farlow, Martin R ^a   Siemers, Eric R ^a   Hutchins, Gary D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Dystonia; PET; RDP parkinsonism

Indexed keywords

CARBON 11; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; PRESYNAPTIC RECEPTOR; TRACER;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DYSTONIA; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMAGING; MALE; MOTOR DYSFUNCTION; NEUROTRANSMITTER UPTAKE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; BRAIN MAPPING; CARBON RADIOISOTOPES; COCAINE; CORPUS STRIATUM; DIAGNOSIS, DIFFERENTIAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DYSTONIA; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PILOT PROJECTS; RECEPTORS, DOPAMINE; RECEPTORS, PRESYNAPTIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032929472     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J     Document Type: Article

References (17)

1. Dobyns WB, Ozelius LJ, Kramer PL, et al. Rapid-onset dystonia-parkinsonism. Neurology 1993;43:2596-2602.
2. Brashear A, Farlow MR, Butler IJ, et al. Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord 1996;11:151-156.
3. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993;34: 423-431.
4. 11C]β-CFT in early Parkinson's disease. Synapse 1995;21:97-103.
5. Brooks DJ. Detection of preclinical Parkinson's disease with PET. Neurology 1991;41:24-27.
6. Leenders KL, Quinn N, Frackowiak RSJ, Marsden CD. Brain dopaminergic system studied in patients with dystonia using positron emission tomography. Adv Neurol 1988;50:243-247.
7. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993;34: 423-431.
8. 3H] WIN 35,428 to central dopamine transporters. Synapse 1996;23:61-69.
9. 11C] methyl Triflate. Appl Radiat Isot 1992;43:1383-1385.
10. 11C]β-CIT labeled at nitrogen or oxygen positions. Nucl Med Biol 1996;23:981-986.
11. Brashear A, DeLeon D, Bressman SB, et al. Rapid-onset dystonia-parkinsonism in a second family. Neurology 1997;48:1066-1069.
12. Nygaard TG, Trugman JM, de Yebenes JG, et al. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69.
13. Moeller JR, Ishikawa G, Dhawan V, et al. The metabolic topography of normal aging. J Cereb Blood Flow Metabol 1996;16:385-398.
14. Snow BJ, Nygaard TG, Takahashi H, et al. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993;34:733-738.
15. 11C]raclopride. J Neurol Sci 1995;132:156-161.
16. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
17. Brashear A, Butler IJ, Hyland K, et al. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 1998;43:521-525.